<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101686084</journal-id>
<journal-id journal-id-type="pubmed-jr-id">45425</journal-id>
<journal-id journal-id-type="nlm-ta">Expert Rev Precis Med Drug Dev</journal-id>
<journal-id journal-id-type="iso-abbrev">Expert Rev Precis Med Drug Dev</journal-id>
<journal-title-group>
<journal-title>Expert review of precision medicine and drug development</journal-title>
</journal-title-group>
<issn pub-type="epub">2380-8993</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29276780</article-id>
<article-id pub-id-type="pmc">5737812</article-id>
<article-id pub-id-type="doi">10.1080/23808993.2017.1284557</article-id>
<article-id pub-id-type="manuscript">NIHMS905068</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The role of epigenomics in personalized medicine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kronfol</surname>
<given-names>Mohamad M.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dozmorov</surname>
<given-names>Mikhail G.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Rong</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Slattum</surname>
<given-names>Patricia W.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McClay</surname>
<given-names>Joseph L.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA</aff>
<aff id="A2">
<label>b</label>Department of Biostatistics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA</aff>
<aff id="A3">
<label>c</label>Department of Medicinal Chemistry, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence to: Joseph L. McClay, Ph.D., Robert Blackwell Smith Building, 410 North 12<sup>th</sup> Street, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298-0533. Tel: +1 804-828 3428, <email>jlmcclay@vcu.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>Declaration of Interest</bold>
</p>
<p>JL McClay received honoraria from the American College of Clinical Pharmacy to present on the topic of pharmacoepigenomics. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>31</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>2</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>45</lpage>
<!--elocation-id from pubmed: 10.1080/23808993.2017.1284557-->
<self-uri xlink:href="http://www.tandfonline.com/doi/abs/10.1080/23808993.2017.1284557"></self-uri>
<abstract>
<sec id="S1">
<title>Introduction</title>
<p id="P1">Epigenetics is the study of reversible modifications to chromatin and their extensive and profound effects on gene regulation. To date, the role of epigenetics in personalized medicine has been under-explored. Therefore, this review aims to highlight the vast potential that epigenetics holds.</p>
</sec>
<sec id="S2">
<title>Areas covered</title>
<p id="P2">We first review the cell-specific nature of epigenetic states and how these can vary with developmental stage and in response to environmental factors. We then summarize epigenetic biomarkers of disease, with a focus on diagnostic tests, followed by a detailed description of current and pipeline drugs with epigenetic modes of action. Finally, we discuss epigenetic biomarkers of drug response.</p>
</sec>
<sec id="S3">
<title>Expert commentary</title>
<p id="P3">Epigenetic variation can yield information on cellular states and developmental histories in ways that genotype information cannot. Furthermore, in contrast to fixed genome sequence, epigenetic patterns are plastic, so correcting aberrant, disease-causing epigenetic marks holds considerable therapeutic promise. While just six epigenetic drugs are currently approved for use in the United States, a larger number is being developed. However, a drawback to current therapeutics is their non-specific effects. Development of locus-specific epigenetic modifiers, used in conjunction with epigenetic biomarkers of response, will enable truly precision interventions.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Chromatin remodeling</kwd>
<kwd>DNA methylation</kwd>
<kwd>DNMT inhibitors</kwd>
<kwd>Epigenetic biomarkers</kwd>
<kwd>Epigenetic drugs</kwd>
<kwd>HDAC inhibitors</kwd>
<kwd>Histone modifications</kwd>
<kwd>Oncology</kwd>
<kwd>Neuroscience</kwd>
<kwd>Pharmacokinetics</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>